Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-03 20:30 | 2026-04-01 | NUVL | Nuvalent, Inc. | Balcom Alexandra | Officer; Chief Financial Officer | Pharmaceutical Preparations | OPT+S | $105.21 | 11,430 | $1,202,526 | 85,533 | -11.8% |
| 2026-04-03 20:53 | 2026-04-01 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Liu Joy | Officer; EVP and Chief Legal Officer | Pharmaceutical Preparations | SALE | $449.17 | 978 | $439,288 | 21,833 | -4.3% |
| 2026-04-03 20:10 | 2026-04-01 | DYN | Dyne Therapeutics, Inc. | Lucera Erick | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $18.64 | 5,727 | $106,751 | 125,373 | -4.4% |
| 2026-04-03 20:24 | 2026-04-01 | TECX | Tectonic Therapeutic, Inc. | Ruddy Marcella K. | Officer; Chief Medical Officer | Biological Products, (No Diagnostic Substances) | SALE | $31.05 | 1,000 | $31,050 | 68,747 | -1.4% |
| 2026-04-03 20:12 | 2026-04-01 | STOK | Stoke Therapeutics, Inc. | Ticho Barry | Officer; CHIEF MEDICAL OFFICER | Pharmaceutical Preparations | SALE | $32.66 | 1,838 | $60,029 | 38,864 | -4.5% |
| 2026-04-03 20:00 | 2026-04-01 | TWST | Twist Bioscience Corp | Starovasnik Melissa A. | Director | Biological Products, (No Diagnostic Substances) | SALE | $51.00 | 1,000 | $51,000 | 25,722 | -3.7% |
| 2026-04-03 20:07 | 2026-04-01 | BIOA | BioAge Labs, Inc. | RUBIN PAUL D | Officer; Chief Medical Officer | Pharmaceutical Preparations | OPT+S | $17.81 | 8,820 | $157,084 | 0 | -100.0% |
| 2026-04-03 20:01 | 2026-04-01 | REGN | REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F | Director | Pharmaceutical Preparations | SALE | $777.27 | 100 | $77,727 | 17,603 | -0.6% |
| 2026-04-03 21:00 | 2026-04-02 | CAPR | CAPRICOR THERAPEUTICS, INC. | Sabar Karimah Es | Director | Pharmaceutical Preparations | OPT+S | $32.00 | 7,529 | $240,928 | 0 | -100.0% |
| 2026-04-03 20:07 | 2026-04-01 | INSM | INSMED Inc | Adsett Roger | Officer; Chief Operating Officer | Pharmaceutical Preparations | OPT+S | $164.63 | 88,060 | $14,497,652 | 106,810 | -45.2% |
| 2026-04-04 01:29 | 2026-04-01 | SYRE | Spyre Therapeutics, Inc. | Burrows Scott L | Officer; Chief Financial Officer | Pharmaceutical Preparations | OPT+S | $49.34 | 7,500 | $370,076 | 97,994 | -7.1% |
| 2026-04-04 01:30 | 2026-04-01 | SYRE | Spyre Therapeutics, Inc. | Sloan Sheldon | Officer; Chief Medical Officer | Pharmaceutical Preparations | OPT+S | $50.00 | 7,958 | $397,900 | 0 | -100.0% |
| 2026-04-04 01:30 | 2026-04-01 | SYRE | Spyre Therapeutics, Inc. | Turtle Cameron | Director, Officer; Chief Executive Officer | Pharmaceutical Preparations | SALE | $49.33 | 15,000 | $739,913 | 627,540 | -2.3% |
| 2026-04-04 00:00 | 2026-04-01 | APGE | Apogee Therapeutics, Inc. | Henderson Jane | Officer; Chief Financial Officer | Biological Products, (No Diagnostic Substances) | SALE | $85.01 | 2,000 | $170,020 | 177,371 | -1.1% |
| 2026-04-04 00:00 | 2026-04-01 | APGE | Apogee Therapeutics, Inc. | Dambkowski Carl | Officer; Chief Medical Officer | Biological Products, (No Diagnostic Substances) | OPT+S | $84.84 | 5,500 | $466,619 | 208,398 | -2.6% |
| 2026-04-03 23:46 | 2026-04-02 | IMNM | Immunome Inc. | Rosett Max | Officer; Chief Financial Officer | Pharmaceutical Preparations | OPT+S | $21.92 | 65,000 | $1,424,917 | 54,037 | -54.6% |
| 2026-04-03 23:48 | 2026-04-02 | IMNM | Immunome Inc. | Higgins Jack | Officer; Chief Scientific Officer | Pharmaceutical Preparations | SALE | $21.64 | 9,438 | $204,238 | 22,000 | -30.0% |
| 2026-04-03 22:17 | 2026-04-02 | WHWK | Whitehawk Therapeutics, Inc. | Lennon David James | Director, Officer; CHIEF EXECUTIVE OFFICER | Pharmaceutical Preparations | OPT+S | $3.48 | 26,858 | $93,466 | 793,549 | -3.3% |
| 2026-04-03 21:55 | 2026-04-02 | VYGR | Voyager Therapeutics, Inc. | Sandrock Alfred | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | SALE | $3.87 | 11,511 | $44,548 | 472,549 | -2.4% |
| 2026-04-03 21:57 | 2026-04-02 | ZLAB | Zai Lab Ltd | Amado Rafael | Officer; See Remarks | Pharmaceutical Preparations | OPT+S | $20.39 | 9,910 | $202,065 | 59,761 | -14.2% |
| 2026-04-03 21:57 | 2026-04-02 | ZLAB | Zai Lab Ltd | Chen Yajing | Officer; Chief Financial Officer | Pharmaceutical Preparations | OPT+S | $20.39 | 5,199 | $106,008 | 32,558 | -13.8% |
| 2026-04-03 21:58 | 2026-04-02 | ZLAB | Zai Lab Ltd | Du Ying | Director, Officer; Chairperson & CEO | Pharmaceutical Preparations | OPT+S | $20.39 | 5,576 | $113,695 | 1,125,279 | -0.5% |
| 2026-04-03 21:58 | 2026-04-02 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | Officer; Chief Legal Officer | Pharmaceutical Preparations | OPT+S | $20.39 | 4,194 | $85,516 | 24,590 | -14.6% |
| 2026-04-03 21:59 | 2026-04-02 | ZLAB | Zai Lab Ltd | Smiley Joshua L | Officer; See Remarks | Pharmaceutical Preparations | OPT+S | $20.39 | 9,614 | $196,029 | 120,619 | -7.4% |
| 2026-04-03 21:45 | 2026-04-01 | XERS | Xeris Biopharma Holdings, Inc. | Hecht Beth | Officer; See Remarks | Pharmaceutical Preparations | SALE | $5.99 | 16,667 | $99,859 | 1,209,840 | -1.4% |
| 2026-04-03 21:46 | 2026-04-01 | ARQT | Arcutis Biotherapeutics, Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $23.88 | 10,000 | $238,801 | 39,744 | -20.1% |
| 2026-04-03 21:09 | 2026-04-01 | JAZZ | Jazz Pharmaceuticals plc | COZADD BRUCE C | Director | Pharmaceutical Preparations | SALE | $190.50 | 6,000 | $1,143,010 | 384,682 | -1.5% |
| 2026-04-03 21:20 | 2026-04-01 | PTCT | PTC THERAPEUTICS, INC. | Almstead Neil Gregory | Officer; CHIEF TECHNICAL OPS OFFICER | Pharmaceutical Preparations | SALE | $69.04 | 52,003 | $3,590,240 | 60,137 | -46.4% |
| 2026-04-03 21:06 | 2026-04-02 | ANVS | Annovis Bio, Inc. | Hoffman Michael B | Director | Pharmaceutical Preparations | BUY | $2.10 | 713,800 | $1,498,980 | 3,288,539 | +27.7% |
| 2026-04-03 20:33 | 2026-04-02 | IMVT | Immunovant, Inc. | Venker Eric | Director, Officer; Chief Executive Officer | Biological Products, (No Diagnostic Substances) | OPT+S | $24.10 | 14,229 | $342,855 | 19,561 | -42.1% |
| 2026-04-03 20:05 | 2026-04-01 | EBS | Emergent BioSolutions Inc. | Williams Paul Anthony | Officer; SVP, Products Business | Pharmaceutical Preparations | SALE | $8.44 | 4,000 | $33,760 | 62,681 | -6.0% |
| 2026-04-03 20:06 | 2026-04-01 | PCVX | Vaxcyte, Inc. | Wassil Jim | Officer; CHIEF OPERATING OFFICER | Biological Products, (No Diagnostic Substances) | SALE | $58.43 | 2,250 | $131,476 | 162,994 | -1.4% |
| 2026-04-03 19:13 | 2026-04-01 | AVTX | Avalo Therapeutics, Inc. | Doyle Mittie | Officer; Chief Medical Officer | Pharmaceutical Preparations | OPT+S | $16.00 | 679 | $10,864 | 3,622 | -15.8% |
| 2026-04-03 19:14 | 2026-04-01 | AVTX | Avalo Therapeutics, Inc. | Sullivan Christopher Ryan | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $16.96 | 15,959 | $270,593 | 17,338 | -47.9% |
| 2026-04-03 13:00 | 2026-04-01 | ERAS | Erasca, Inc. | Garner Ebun | Officer; Chief Legal Officer | Pharmaceutical Preparations | OPT+S | $16.40 | 80,000 | $1,312,000 | 25,076 | -76.1% |
| 2026-04-03 11:29 | 2026-04-01 | CGEN | COMPUGEN LTD | Ophir Eran | Director, Officer; President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $2.21 | 5,625 | $12,413 | 11,375 | -33.1% |
| 2026-04-03 11:31 | 2026-04-01 | CGEN | COMPUGEN LTD | Levine Zurit | Officer; SVP, Business Development | Biological Products, (No Diagnostic Substances) | OPT+S | $2.20 | 3,500 | $7,700 | 29,375 | -10.6% |
| 2026-04-02 20:06 | 2026-04-01 | MAZE | Maze Therapeutics, Inc. | Bachrodt Amy | Officer; SVP, Finance | Biological Products, (No Diagnostic Substances) | OPT+S | $29.44 | 2,500 | $73,611 | 12,965 | -16.2% |
| 2026-04-02 20:08 | 2026-04-01 | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | Officer; President, R&D & CMO | Biological Products, (No Diagnostic Substances) | OPT+S | $29.46 | 15,000 | $441,905 | 0 | -100.0% |
| 2026-04-02 21:58 | 2026-04-01 | RPRX | Royalty Pharma plc | Coyne Terrance P. | Officer; EVP & CFO | Pharmaceutical Preparations | SALE | $48.33 | 34,791 | $1,681,512 | 32,916 | -51.4% |
| 2026-04-02 20:16 | 2026-03-31 | CGC | Canopy Growth Corp | Yanofsky Theresa | Director | Medicinal Chemicals & Botanical Products | SALE | $0.93 | 10,373 | $9,647 | 53,145 | -16.3% |
| 2026-04-02 20:15 | 2026-03-31 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Director | Medicinal Chemicals & Botanical Products | SALE | $0.93 | 15,624 | $14,530 | 72,048 | -17.8% |
| 2026-04-02 20:47 | 2026-03-31 | ALLO | Allogene Therapeutics, Inc. | Beneski Benjamin Machinas | Officer; SVP, Chief Technical Officer | Biological Products, (No Diagnostic Substances) | SALE | $2.50 | 2,867 | $7,168 | 195,338 | -1.4% |
| 2026-04-02 20:39 | 2026-04-01 | TRDA | Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $12.95 | 2,500 | $32,375 | 119,010 | -2.1% |
| 2026-04-02 21:12 | 2026-03-31 | PCSA | Processa Pharmaceuticals, Inc. | Neal James R | Director | Pharmaceutical Preparations | BUY | $2.54 | 789 | $2,000 | 818 | +2,720.7% |
| 2026-04-02 21:55 | 2026-04-01 | TVTX | Travere Therapeutics, Inc. | Dube Eric M | Director, Officer; CHIEF EXECUTIVE OFFICER | Pharmaceutical Preparations | OPT+S | $30.93 | 60,000 | $1,855,842 | 432,886 | -12.2% |
| 2026-04-02 20:29 | 2026-04-01 | BMY | BRISTOL MYERS SQUIBB CO | Elkins David V | Officer; EVP, Chief Financial Officer | Pharmaceutical Preparations | SALE | $61.67 | 30,000 | $1,850,016 | 159,248 | -15.9% |
| 2026-04-02 21:55 | 2026-04-01 | TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | Officer; Chief Legal Officer and GC | Pharmaceutical Preparations | OPT+S | $30.00 | 10,000 | $300,000 | 105,211 | -8.7% |
| 2026-04-02 20:16 | 2026-03-31 | CGC | Canopy Growth Corp | ATKINS M SHAN | Director | Medicinal Chemicals & Botanical Products | SALE | $0.93 | 2,074 | $1,929 | 41,390 | -4.8% |
| 2026-04-02 20:15 | 2026-03-31 | CGC | Canopy Growth Corp | BAYERN JOSEPH | Director | Medicinal Chemicals & Botanical Products | SALE | $0.93 | 2,658 | $2,472 | 40,000 | -6.2% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.